Flushing Financial Corp. (FFIC) Jumps 5.28% on February 16

Equities Staff  |

Flushing Financial Corp. (FFIC) was among the biggest gainers on the Russell 2000 for Tuesday February 16 as the stock popped 5.28% to $20.93, representing a gain of $1.05 per share. Some 75,617 shares traded hands on 710 trades, compared with an average daily volume of 85,753 shares out of a total float of 28.83 million. The stock opened at $20.16 and traded with an intraday range of $21.09 to $19.84.

After today's gains, Flushing Financial Corp. reached a market cap of $603.42 million. Flushing Financial Corp. has had a trading range between $23.07 and $18.77 over the last year, and it had a 50-day SMA of $20.95 and a 200-day SMA of $20.45.

The stock has a P/E Ratio of 12.4.

Flushing Financial Corp attracts retail deposits from the general public and invests those deposits together with funds generated from ongoing operations and borrowings.

Flushing Financial Corp. is based out of New York, NY and has some 424 employees. Its CEO is .

For a complete fundamental analysis analysis of Flushing Financial Corp., check out Equities.com’s Stock Valuation Analysis report for FFIC. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Investview Inc

Investview Inc is an investor technology and education company. It provides products that allow the individual investor to find, analyze, track, and manage their portfolio.